<code id='0E54CD318B'></code><style id='0E54CD318B'></style>
    • <acronym id='0E54CD318B'></acronym>
      <center id='0E54CD318B'><center id='0E54CD318B'><tfoot id='0E54CD318B'></tfoot></center><abbr id='0E54CD318B'><dir id='0E54CD318B'><tfoot id='0E54CD318B'></tfoot><noframes id='0E54CD318B'>

    • <optgroup id='0E54CD318B'><strike id='0E54CD318B'><sup id='0E54CD318B'></sup></strike><code id='0E54CD318B'></code></optgroup>
        1. <b id='0E54CD318B'><label id='0E54CD318B'><select id='0E54CD318B'><dt id='0E54CD318B'><span id='0E54CD318B'></span></dt></select></label></b><u id='0E54CD318B'></u>
          <i id='0E54CD318B'><strike id='0E54CD318B'><tt id='0E54CD318B'><pre id='0E54CD318B'></pre></tt></strike></i>

          fashion

          fashion

          author:focus    Page View:44136
          STAT

          What if CRISPR isn’t all that commercial? How does the NurOwn story end? And how do you pronounce “Bayer”?

          We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Live from Boston at the 2023 STAT Summit, we discuss the latest news in the life sciences, including a milestone in genome editing, a twist in the search for ALS treatments, and the polarizing process of saying words in biotech.

          advertisement

          For more on what we cover, here’s the latest from the Summit; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

          Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

          And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

          advertisement

          explore

          Apple is now the first public company to be valued at $3 trillion
          Apple is now the first public company to be valued at $3 trillion

          6:09FILE-AnApplelogoadornsthefacadeofthedowntownBrooklynApplestoreonMarch14,2020,inNewYork.Applebeca

          read more
          Ultragenyx gene therapy for rare liver ailment succeeds in late
          Ultragenyx gene therapy for rare liver ailment succeeds in late

          JonathanWiggs/GlobeStaffUltragenyxsaidThursdayafternoonthatitsgenetherapyforarareliverailment,glycog

          read more
          Trump demands the U.S. pay no more for drugs than other countries … again
          Trump demands the U.S. pay no more for drugs than other countries … again

          EthanMiller/GettyImagesWASHINGTON—FormerPresidentTrumpisbacktocampaigningfortyingMedicaredrugpricest

          read more

          Let's speed up science by embracing open access publishing

          APStockSixyearsago,HarvardscientistJayBradnerdiscoveredsomethingunusual.Hislaboratoryhadisolatedamol